ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629974 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629974; 2) Community: the network communities that were significantly associated with the response to NSC 629974; 3) Molecule: the relationships between components within communities and NSC 629974; 4) MDR: the compounds that were significantly associated with the NSC 629974.

NSC Compound Enrichment Correlation
NSC 671888 Null 0.0382675857669587 0.43322007
NSC 673791 Null 0.0382675857669587 0.33929979
NSC 716679 Null 0.0382675857669587 0.59497087
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0382675857669587 -0.42062049
NSC 632608 Diammine-1,7,10,16-tetraoxa-4,13-diazacyclooctadecane- platinum(II)dichloride 0.0382675857669588 0.056215631
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.0382675857669588 0.56282195
NSC 661583 TRIBUTYRIN 0.0382675857669588 0.23034066
NSC 666765 Null 0.0382675857669588 0.36184462
NSC 676788 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-L-arabinopyranosyl] ester 0.0382675857669588 -0.025444873
NSC 681634 Camptothecin Derivative 0.0382675857669588 0.018234013
Total:61  Current:49    [First] [Prev] [Next] [Last]